Regulatory pathways & compliance guide

Plan for regulation early so your experiments, prototypes, and validation studies support translation instead of blocking it.

Why this guide matters

Regulatory expectations influence study design, evidence collection, labeling, manufacturing controls, and partner selection. Teams that identify likely regulatory pathways early save time and avoid costly rework—whether they are an academic lab preparing a first-in-human study, a startup validating a diagnostic, a medtech team prototyping a device, a software group developing a clinical decision support tool, or a manufacturer adapting a process for regulated output.

What you will understand and be able to do

• Recognize common regulatory categories and decision points relevant to research translation (e.g., device vs. diagnostic vs. drug vs. software-as-a-medical-device) and why the distinction matters for study design and evidence.
• Map basic documentation and quality expectations you should plan for—protocols, risk assessments, verification/validation records, traceability, and labeling—so your team collects reproducible, auditable evidence.
• Identify early practical steps: stakeholder mapping (safety, IRB/ethics, quality, commercialization), jurisdictional considerations, and when to consult regulatory or clinical specialists.
• Use available templates—such as the included product development & validation project template—to structure studies, capture requirements, and translate findings into regulatory-ready records.

How this fits the Research & Discovery and Translation context

This resource belongs to Research & Discovery and is intended to bridge rigorous research practices and real-world translation. It complements translation playbooks and IP planning: good regulatory planning preserves reproducibility and evidence quality while helping teams choose appropriate validation strategies, partners, and commercialization milestones.

Practical examples

- A neuroscience lab planning a pilot human study will learn which documentation and ethics approvals to align with safety and data standards so results remain usable for later device or therapeutic claims.

- A startup building a point-of-care diagnostic will see how early verification criteria and manufacturing controls reduce surprises during regulatory review.

- A software team developing an analysis tool will learn when to treat the product as clinical software and which validation traces strengthen regulatory conversations.

How to use this resource on THE

The guide provides a concise overview plus a product development & validation project template you can copy and adapt for your context. Consider converting checklists into THE interactive forms or audits to capture structured evidence and store responses for traceability and later review.